RecruitingNCT05653011

Predictors of Prognosis in IBD Patients

Predictors of Response After Induction Therapy With TNF-alpha Inhibitor in Inflammatory Bowel Disease, Comparison to Normal

Sponsor

Seoul National University Bundang Hospital

Enrollment

100 participants

Start Date

Mar 11, 2013

Study Type

OBSERVATIONAL

Conditions

Inflammatory Bowel Diseases Crohn Disease Ulcerative Colitis

Summary

A study of clinical characteristics and potential prognostic factors in inflammatory bowel disease

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Endoscopic biopsy for people with crohn disease, inflammatory bowel diseases, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHEREndoscopic biopsy

When patients have colonoscopy or sigmoidoscopy for evaluation of their disease course, biopsied samples are collected. In the IBD group, samples are obtained at endoscopically active and/or inactive lesions. In the control group, samples are obtained at endoscopically normal lesions.